Array Biopharma, Inc. (ARRY) Tops Q2 EPS by 4c
Array Biopharma, Inc. (NASDAQ: ARRY) reported Q2 EPS of ($0.10) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
